ING Group’s Encompass Health EHC Stock Holding History

ING Group’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,200	Closed	-$793K	–	553
2026 Q1	$793K	Hold	8,200	–	–	﹤0.01%	450
2025 Q4	$870K	Hold	8,200	–	–	0.01%	489
2025 Q3	$1.04M	Buy	+8,200	New	+$976K	0.01%	436
2022 Q1	–	Sell	-18,352	Closed	-$953K	–	552
2021 Q4	$953K	Buy	+18,352	New	+$947K	0.01%	575
2019 Q3	–	Sell	-19,046	Closed	-$960K	–	565
2019 Q2	$960K	Buy	19,046 +26	+0.1%	+$1.26K	0.02%	389
2019 Q1	$884K	Sell	19,020 -41	-0.2%	-$2.08K	0.02%	336
2018 Q4	$936K	Buy	19,061 +64	+0.3%	+$3.64K	0.02%	342
2018 Q3	$1.18M	Buy	18,997 +5,919	+45%	+$360K	0.02%	339
2018 Q2	$705K	Buy	+13,078	New	+$654K	0.01%	396
2018 Q1	–	Sell	-18,727	Closed	-$736K	–	761
2017 Q4	$736K	Buy	+18,727	New	+$712K	0.01%	398

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ING Group's EHC Position: Q2 2026 in Review

ING Group sold out of Encompass Health (EHC) in Q2 2026, closing a stake of 8,200 shares — an estimated $793K sold.

ING Group first reported a position in EHC in Q4 2017 and held it in 10 quarters. The position peaked at $1.18M in Q3 2018. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

ING Group reported no remaining Encompass Health position as of Q2 2026 after selling out during the quarter.
ING Group sold 8,200 Encompass Health shares in Q2 2026, an estimated $793K.
ING Group first reported a position in Encompass Health in Q4 2017 and held it in 10 quarters.
ING Group's Encompass Health position peaked at $1.18M in Q3 2018.
597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.